Small molecule drug manufacturing plant

By using AI to model cell culture conditions and predict yield, cell lines with high antibody performance potential can be identified, helping research teams significantly reduce the number of candidate cells that need to be actually cultured and validated.

Client Challenge

This company focuses on API manufacturing.
Traditional process optimization relies heavily on expert experience and sequential testing, adjusting only a few parameters at a time.
This makes it difficult to evaluate multi-parameter interactions, resulting in long development cycles and inefficient use of resources.

The client needed a systematic approach to parameter selection and process optimization to reduce cycle time and dependence on experiential decision-making.

Solution Implemented

The client deployed Process Parameters and Process Optimax AI Agents.
Using extensive historical process data, the models identified enabling and limiting factors, provided importance rankings, and recommended adjustment strategies.
AI-driven optimization reduced reliance on experience, shortened testing cycles, and improved decision-making while maintaining quality stability.

Results Achieved

The client validated the model-recommended adjustments through small-batch experiments, demonstrating significant improvements in product yield and shorter development time.
With AI-guided factor selection, the process optimization workflow became faster, more systematic, and more effective—proving therapiAI AI Agents’ practicality and impact in real production environments.

More

More Case Studies

Client Challenge This

By using AI to model cell culture conditions and predict yield, cell lines with high antibody performance potential can be identified, helping research teams significantly reduce the number of candidate cells that need to be actually cultured and validated.

Continue Reading

Scroll to Top